financetom
Business
financetom
/
Business
/
Targa Resources Q3 adjusted EBITDA up 19%, beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Targa Resources Q3 adjusted EBITDA up 19%, beats estimates
Nov 5, 2025 3:40 AM

Overview

* Targa Q3 adjusted EBITDA beats analyst expectations, rising 19% year-over-year

* Company Q3 revenue misses analyst expectations despite increase in net income

* Targa repurchased $156 mln of common stock in Q3, continuing share buyback strategy

Outlook

* Targa estimates full-year 2025 adjusted EBITDA at top end of $4.65 bln to $4.85 bln range

* Company plans to recommend $5.00 annual dividend per share in 2026, a 25% increase

* Targa moving forward with new gas plants and pipelines in Permian Basin

Result Drivers

* PERMIAN VOLUMES - Record natural gas inlet volumes in the Permian Basin contributed to higher adjusted operating margins

* NGL TRANSPORTATION - Record NGL pipeline transportation and fractionation volumes drove increased segment margins

* NEW FACILITIES - Commencement of operations at new plants like Bull Moose II enhanced capacity and supported growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $4.15 $4.56

Revenue bln bln (6

Analysts

)

Q3 Net $486.60

Income mln

Q3 Beat $1.27 $1.20

Adjusted bln bln (17

EBITDA Analysts

)

Q3 $1.08

Adjusted bln

Free

Cash

Flow

Q3 $333.50

Operatin mln

g

Expenses

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas transportation services peer group is "buy"

* Wall Street's median 12-month price target for Targa Resources Corp ( TRGP ) is $200.00, about 22.7% above its November 4 closing price of $154.57

* The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 20 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cruise operator Royal Caribbean beats Q3 adjusted EPS expectations, lifts FY forecast
Cruise operator Royal Caribbean beats Q3 adjusted EPS expectations, lifts FY forecast
Oct 28, 2025
Overview * Royal Caribbean Q3 adjusted EPS beats analyst expectations, driven by strong demand and lower costs * Company raises full-year 2025 adjusted EPS guidance to $15.58-$15.63, up 32% yr/yr Outlook * Royal Caribbean raises 2025 Adjusted EPS guidance to $15.58-$15.63 * Company says 2026 bookings have come in at rates well above the prior year * Company expects 2026...
Curbline Properties Q3 Operating FFO, Revenue Rise; Annual Operating FFO Guidance Upgraded
Curbline Properties Q3 Operating FFO, Revenue Rise; Annual Operating FFO Guidance Upgraded
Oct 28, 2025
06:44 AM EDT, 10/28/2025 (MT Newswires) -- Curbline Properties ( CURB ) reported Q3 operating funds from operations Tuesday of $0.28 per diluted share, up from $0.19 a year earlier. Four analysts polled by FactSet expected $0.27. Revenue for the quarter ended Sept. 30 was $48.6 million, up from $29.8 million a year earlier. Analysts surveyed by FactSet expected $42.9...
Zebra Technologies Q3 sales edge past estimates on lower-than-expected tariff impact
Zebra Technologies Q3 sales edge past estimates on lower-than-expected tariff impact
Oct 28, 2025
Overview * Zebra Q3 net sales rise 5.2% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats analyst expectations, reflecting strong operational performance * Company plans $500 mln share repurchase over next 12 months Outlook * Company expects Q4 sales growth between 8% and 11% * Adjusted EBITDA margin for Q4 expected to be around 22% * Non-GAAP EPS...
Regeneron Pharma's Q3 profit beats on Dupixent strength
Regeneron Pharma's Q3 profit beats on Dupixent strength
Oct 28, 2025
Overview * Regeneron Q3 2025 revenue grows 1% to $3.75 bln, beating analyst expectations * Adjusted EPS for Q3 2025 beats consensus, driven by strong product sales * Company reports strong sales growth for Dupixent and EYLEA HD Outlook * Regeneron updates 2025 R&D expense guidance to $5.68-$5.75 bln * Company revises 2025 SG&A expense guidance to $2.775-$2.845 bln *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved